Article Dans Une Revue Molecular Psychiatry Année : 2021

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms

Dates et versions

hal-03367624 , version 1 (06-10-2021)

Identifiants

Citer

Nicolas Hoertel, Marina Sánchez-Rico, Céline Cougoule, Erich Gulbins, Johannes Kornhuber, et al.. Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms. Molecular Psychiatry, 2021, 26 (12), pp.7098-7099. ⟨10.1038/s41380-021-01254-3⟩. ⟨hal-03367624⟩
61 Consultations
0 Téléchargements

Altmetric

Partager

  • More